With two debuts and a SPAC, biopharma notches another busy week as IPO raise soars past $7B
Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.
After a slight lull in the IPO market …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
